These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 18417583)

  • 1. Infection with Vpr-positive human immunodeficiency virus type 1 impairs NK cell function indirectly through cytokine dysregulation of infected target cells.
    Majumder B; Venkatachari NJ; O'Leary S; Ayyavoo V
    J Virol; 2008 Jul; 82(14):7189-200. PubMed ID: 18417583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exogenous HIV-1 Vpr disrupts IFN-alpha response by plasmacytoid dendritic cells (pDCs) and subsequent pDC/NK interplay.
    Hong HS; Bhatnagar N; Ballmaier M; Schubert U; Henklein P; Volgmann T; Heiken H; Schmidt RE; Meyer-Olson D
    Immunol Lett; 2009 Aug; 125(2):100-4. PubMed ID: 19559726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 Vpr up-regulates expression of ligands for the activating NKG2D receptor and promotes NK cell-mediated killing.
    Richard J; Sindhu S; Pham TN; Belzile JP; Cohen EA
    Blood; 2010 Feb; 115(7):1354-63. PubMed ID: 20008788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired plasmacytoid dendritic cell (PDC)-NK cell activity in viremic human immunodeficiency virus infection attributable to impairments in both PDC and NK cell function.
    Conry SJ; Milkovich KA; Yonkers NL; Rodriguez B; Bernstein HB; Asaad R; Heinzel FP; Tary-Lehmann M; Lederman MM; Anthony DD
    J Virol; 2009 Nov; 83(21):11175-87. PubMed ID: 19692459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of natural killer and antibody-dependent cytolytic activities of the peripheral blood mononuclear cells of HIV-infected patients by recombinant IL-15.
    Loubeau M; Ahmad A; Toma E; Menezes J
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Nov; 16(3):137-45. PubMed ID: 9390564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-10
    Jiang Y; Yang M; Sun X; Chen X; Ma M; Yin X; Qian S; Zhang Z; Fu Y; Liu J; Han X; Xu J; Shang H
    BMC Infect Dis; 2018 Feb; 18(1):80. PubMed ID: 29439673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuronal apoptosis by HIV-1 Vpr: contribution of proinflammatory molecular networks from infected target cells.
    Guha D; Nagilla P; Redinger C; Srinivasan A; Schatten GP; Ayyavoo V
    J Neuroinflammation; 2012 Jun; 9():138. PubMed ID: 22727020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional analyses of natural killer cells in macaques infected with neurovirulent simian immunodeficiency virus.
    Shieh TM; Carter DL; Blosser RL; Mankowski JL; Zink MC; Clements JE
    J Neurovirol; 2001 Feb; 7(1):11-24. PubMed ID: 11519478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional Perturbation of Mucosal Group 3 Innate Lymphoid and Natural Killer Cells in Simian-Human Immunodeficiency Virus/Simian Immunodeficiency Virus-Infected Infant Rhesus Macaques.
    Hueber B; Curtis AD; Kroll K; Varner V; Jones R; Pathak S; Lifton M; Van Rompay KKA; De Paris K; Reeves RK
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31801861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased natural killer cell activity in viremic HIV-1 infection.
    Alter G; Malenfant JM; Delabre RM; Burgett NC; Yu XG; Lichterfeld M; Zaunders J; Altfeld M
    J Immunol; 2004 Oct; 173(8):5305-11. PubMed ID: 15470077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virion-associated Vpr of human immunodeficiency virus type 1 triggers activation of apoptotic events and enhances fas-induced apoptosis in human T cells.
    Arokium H; Kamata M; Chen I
    J Virol; 2009 Nov; 83(21):11283-97. PubMed ID: 19692467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human immunodeficiency virus (HIV) type 1 Vpr induces differential regulation of T cell costimulatory molecules: direct effect of Vpr on T cell activation and immune function.
    Venkatachari NJ; Majumder B; Ayyavoo V
    Virology; 2007 Feb; 358(2):347-56. PubMed ID: 17023015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conferral of enhanced natural killer cell function by KIR3DS1 in early human immunodeficiency virus type 1 infection.
    Long BR; Ndhlovu LC; Oksenberg JR; Lanier LL; Hecht FM; Nixon DF; Barbour JD
    J Virol; 2008 May; 82(10):4785-92. PubMed ID: 18305035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vpr Enhances Tumor Necrosis Factor Production by HIV-1-Infected T Cells.
    Roesch F; Richard L; Rua R; Porrot F; Casartelli N; Schwartz O
    J Virol; 2015 Dec; 89(23):12118-30. PubMed ID: 26401039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between human immunodeficiency virus (HIV)-1 Vpr expression and innate immunity influence neurovirulence.
    Na H; Acharjee S; Jones G; Vivithanaporn P; Noorbakhsh F; McFarlane N; Maingat F; Ballanyi K; Pardo CA; Cohen EA; Power C
    Retrovirology; 2011 Jun; 8():44. PubMed ID: 21645334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro infection of natural killer cells with different human immunodeficiency virus type 1 isolates.
    Chehimi J; Bandyopadhyay S; Prakash K; Perussia B; Hassan NF; Kawashima H; Campbell D; Kornbluth J; Starr SE
    J Virol; 1991 Apr; 65(4):1812-22. PubMed ID: 1672164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of natural killer cell activity in human immunodeficiency virus-infected subjects by in vitro treatment with biologic response modifier OK-432.
    Huang XL; Fan Z; Murayama T; Rinaldo C
    Clin Diagn Lab Immunol; 1995 Jan; 2(1):91-7. PubMed ID: 7719919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral protein R upregulates expression of ULBP2 on uninfected bystander cells during HIV-1 infection of primary CD4+ T lymphocytes.
    Richard J; Pham TN; Ishizaka Y; Cohen EA
    Virology; 2013 Sep; 443(2):248-56. PubMed ID: 23726848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-21 augments natural killer effector functions in chronically HIV-infected individuals.
    Strbo N; de Armas L; Liu H; Kolber MA; Lichtenheld M; Pahwa S
    AIDS; 2008 Aug; 22(13):1551-60. PubMed ID: 18670213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced Expression of Siglec-7, NKG2A, and CD57 on Terminally Differentiated CD56
    Zulu MZ; Naidoo KK; Mncube Z; Jaggernath M; Goulder PJR; Ndung'u T; Altfeld M; Thobakgale CF
    AIDS Res Hum Retroviruses; 2017 Dec; 33(12):1205-1213. PubMed ID: 28810810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.